NORD Holding and 1Q Health Group Acquire Gelpell AG

Munich –– McDer­mott Will & Schulte advi­sed the funds advi­sed by NORD Holding and their port­fo­lio company, 1Q Health Group, on the acqui­si­tion of the Swiss company Gelpell AG.
Gelpell specia­li­zes in the deve­lo­p­ment and contract manu­fac­tu­ring of soft gela­tin capsu­les, hard capsu­les, and vege­ta­rian capsules.

Head­quar­te­red in Switz­er­land, Gelpell offers services across the entire value chain—from product deve­lo­p­ment and contract manu­fac­tu­ring to regu­la­tory support and pack­a­ging solu­ti­ons. The company also has specia­li­zed exper­tise in the field of its paten­ted GELPELL Beads tech­no­logy. — Gelpell AG deve­lops and manu­fac­tures soft gela­tin capsu­les (soft­gels), hard capsu­les, and vege­ta­rian capsu­les on a contract basis. It offers a full range of services, from product deve­lo­p­ment and regu­la­tory support to pack­a­ging solu­ti­ons and flexi­ble batch sizes. 

The 1Q Health Group is a leading Euro­pean CDMO and deve­lo­p­ment part­ner for premium phar­maceu­ti­cals and dietary supple­ments. With the acqui­si­tion of Gelpell AG, the Group is streng­thening its presence in the DACH region and expan­ding its port­fo­lio to include soft gela­tin capsu­les. In addi­tion, exis­ting share­hol­ders Kris­tina Edvins­son and Tomas Edvins­son, as well as CEO Thomas Jager, are taking an equity stake in 1Q Health Group. 

NORD Holding is a private equity and asset manage­ment firm with appro­xi­m­ately 4 billion euros in assets under management.

McDer­mott has been advi­sing NORD Holding since the estab­lish­ment of the 1Q Health Group and, among other things, assis­ted with the acqui­si­tion of ABJ alive GmbH and HKS health solutions—which were used to create the platform—as well as the subse­quent add-on acqui­si­ti­ons of Viva­Cell Biotech­no­logy GmbH, Beauty Produc­tion GmbH, EHF Produc­tion B.V., and now Gelpell AG.

Bär & Karrer provi­ded legal coun­sel on matters of Swiss law.

Advi­sor NORD Holding: McDer­mott Will & Schulte, Munich

Holger H. Ebers­ber­ger, LL.M., Dr. Thomas Diek­mann (both lead coun­sel, Private Equity); Asso­cia­tes: Dr. Svenja Hefner, Tobias Thie­mann (both Private Equity)